Vimentin and desmin are intermediate filament proteins found in various mesenchymal and skeletal muscle cells, respectively. These proteins play an important role in the stabilization of the cytoplasmic architecture. Here, we found, using artificial biomimicking glycopolymers, that vimentin and desmin possess N-acetylglucosamine (GlcNAc)-binding lectin-like properties on the cell surfaces of various vimentin-and desmin-expressing cells such as cardiomyocytes and vascular smooth muscle cells. The rod II domain of these proteins was demonstrated to be localized to the cell surface and to directly bind to the artificial biomimicking GlcNAc-bearing polymer, by confocal laser microscopy and surface plasmon resonance analysis. These glycopolymers strongly interact with lectins and are useful tools for the analysis of lectin-carbohydrate interactions, since glycopolymers binding to lectins can induce the clustering of lectins due to multivalent glycoside ligand binding. Moreover, immunocytochemistry and pull-down assay with His-tagged vimentin-rod II domain protein showed that the vimentin-rod II domain interacts with O-GlcNAc proteins. These results suggest that OGlcNAc proteins might be one candidate for physiological GlcNAc-bearing ligands with which vimentin and desmin interact. These findings demonstrate a novel function of vimentin and desmin that does not involve stabilization of the cytoplasmic architecture by which these proteins interact with physiological GlcNAc-bearing ligands such as OGlcNAc proteins on the cell surface through their GlcNAcbinding lectin-like properties.
Introduction
Identification of novel lectins in various cells is expected to reveal new physiological functions of lectins in inflammatory responses and to promote the therapeutic use of lectins against diseases via the development of novel drug and cell delivery systems (Misawa et al. 2006; Aso et al. 2007; Naeem et al. 2007 ; Kobayashi et al. 2009 ). We therefore searched for previously undescribed cell surface lectins in cardiovascular tissues. Novel lectins have been reported in other tissues. Thus, for example, it has recently been reported that the Na + /K + -ATPase β-subunit in mouse brain confers a K + -dependent cell adhesion to β-N-acetylglucosamine (GlcNAc)-terminating glycans (Kitamura et al. 2005) . To identify new cell surface lectins in cardiomyocytes and vascular smooth muscle cells (VSMCs), we used glycopolymers (poly [N-p-vinylbenzyl-O-carbohydrate] [PV-sugars]) as multivalent ligand probes for lectins. Lectincarbohydrate interactions typically occur with lower affinity than protein-protein interactions. However, since most lectins bind with high specificity to multiple glycan moieties, the avidity between glycosides and lectins is significant. Moreover, many lectin-carbohydrate interactions that occur at cell surfaces are intrinsically multivalent (Lee and Lee 1994; Ohtsubo and Marth 2006) . PV-sugars are composed of hydrophilic carbohydrates such as lactose (LA), glucose, galactose, mannose (Man), maltose (MA), and GlcNAc, together with a hydrophobic vinylbenzyl moiety, and they are classified as multivalent glycoside ligands. The distal monosaccharide is intact and is linked through an open-chain monosaccharide to the polymer backbone. Since the molecular weight of these polymers is presumed to be approximately 50,000 and that of the monomer is 557, the number of glycoside ligands of these polymers is estimated to be approximately 90 per molecule. Therefore, PV-sugars can strongly interact with, and cluster, lectins due to the presence of the multivalent carbohydrates. Moreover, these polymers are strongly adsorbed on polystyrene dishes owing to their amphiphilic nature (Kobayashi et al. 1983) . We previously reported the culture of hepatocytes on dishes coated with an LA-bearing polymer (poly [N-p-vinylbenzyl- (Kobayashi et al. 1994; Ise et al. 2004) . PV-sugars are ideal for the detection of new cell surface lectins using this method. Here, we performed carbohydrate adhesion assays using dishes coated with various PV-sugars to determine whether cardiomyocytes and VSMCs express cell surface lectins that can bind to these sugars. The results revealed that cardiomyocytes and VSMCs interact with the GlcNAc-bearing polymer (poly [N-p-vinylbenzyl-O-2-acetoamide-2-deoxy-β-D-glucopyranosyl-(1→4)-2-acetoamide-2-deoxy-β-D-gluconamide] [PVGlcNAc]), suggesting that these cells express cell surface lectins that bind to GlcNAc. The intermediate filament proteins vimentin and desmin were identified as possible novel cell surface lectins, and the rod II domain of these proteins was found to bind to PV-GlcNAc on cell surfaces. 3D structural docking simulations between PV-GlcNAc and the rod II domain revealed that the interactions were induced by tetrameric complexes of the rod II domains. We previously reported that cardiomyocytes internalize GlcNAc-conjugated liposomes (GlcNAc-Ls) (Aso et al. 2007 ). The present study revealed that the internalization of GlcNAc-Ls depends on vimentin and desmin. These findings suggest that vimentin and desmin are actively involved in the internalization of physiological GlcNAc-bearing ligands on cell surfaces. Moreover, the interaction of vimentin-rod II domain protein with O-GlcNAc proteins was examined by immunocytochemistry and pull-down assay with His-tagged vimentin-rod II domain protein. Confocal laser microscopy and the pull-down assay revealed that vimentin-rod II domain protein interacted with O-GlcNAc proteins. These findings suggest that one of the physiological ligands for vimentin and desmin might be O-GlcNAc proteins.
O-β-D-galactopyranosyl-(1→4)-D-gluconamide] [PV-LA]) as a model ligand of asialoglycoprotein receptors
Vimentin and desmin are the major intermediate filament proteins in mesenchymal cells, skeletal muscle cells, smooth muscle cells and cardiomyocytes. These proteins are important for the stabilization of cell structure and architecture because they connect many cytoplasmic components such as the nucleus, endoplasmic reticulum and mitochondria. They also play a significant role in supporting and anchoring the position of the organelles in the cytoplasm (Katsumoto et al. 1990; Goldman et al. 1996) . Recent studies have revealed the roles of vimentin, as vimentin has been shown to participate in a number of critical functions, often related to organization of proteins that are involved in adhesion, migration and cell signaling (Ivaska et al. 2007 ).
The findings found in this study suggest a novel function of vimentin and desmin that are different from the abovementioned roles and would help to elucidate unknown physiological relevance of various diseases and biological phenomena in which vimentin and desmin are involved.
Results

Cardiomyocytes and VSMCs interact with PV-GlcNAc
To determine whether cardiomyocytes and VSMCs interact with carbohydrates, we performed a carbohydrate cell-adhesion assay by incubating these cells at 4°C for 1 h in wells coated with various PV-sugars. The number of cardiomyocytes and VSMCs that adhered to the wells was estimated using the methylthiazoletetrazolium (MTT) assay. Cardiomyocytes and VSMCs strongly adhered to the PV-GlcNAc-coated wells but not to wells coated with other PV-sugars or with bovine serum albumin (BSA) (Figure 1A and C) .
Competition experiments were carried out to confirm the specificity of GlcNAc binding and the importance of multivalency in this binding. The adhesion of cardiomyocytes and VSMCs to PV-GlcNAc-coated wells was competitively inhibited by 50 and 10 μg/mL of soluble PV-GlcNAc, respectively, but not by a soluble MA-bearing polymer (PV-MA) (Figure 1B and D) . Furthermore, a GlcNAc monosaccharide also did not inhibit cell binding. This result suggested that the interaction of the cell surface lectins with multivalent glycoside ligands is stronger than that with monovalent glycoside ligands such as monosaccharides. Furthermore, all of the cell-sugar adhesions were independent of calcium ions ( Figure 1E and F) . In contrast to cardiomyocytes, rat primary hepatocytes did not adhere to the PV-GlcNAc-coated wells, although they strongly adhered to wells coated with galactose-bearing polymers (PV-LA and PV-MEA [melibiose]), glucose-bearing polymers (PV-Lam [laminaribiose] and PV-CA [cellobiose]) and mannose-bearing polymers (PV-Man) ( Figure 1G ). Thus, we postulated that cardiomyocytes and VSMCs, but not rat primary hepatocytes, might express GlcNAc-binding lectin-like proteins on their cell surfaces that bind sugar in a calcium ion-independent manner.
Identification of a GlcNAc-binding lectin(s) in cardiomyocytes and VSMCs
To identify a GlcNAc-binding lectin(s) in cardiomyocytes and VSMCs that bind in a calcium-independent manner, ligand blot analysis using flourescein isothiocyanate (FITC)-PV-GlcNAc was performed. Soluble and insoluble protein fractions prepared from the cells were resolved by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) under denaturing and reducing conditions. The proteins resolved in the gel were then renatured by the removal of SDS, blotted onto polyvinylidene difluoride membranes and analyzed for their binding to a FITC-PV-GlcNAc probe. Only a doublet (cardiomyocytes) and a single band (VSMCs), of approximately 53 kDa molecular weight, present in both the soluble and the insoluble fractions of cardiomyocytes and VSMCs, were found to bind the sugar probe ( Figure 2A ). Competition binding experiments using unlabeled PV-GlcNAc confirmed that cell binding was mediated via GlcNAc. Furthermore, binding was specific to GlcNAc since no binding of another sugar probe, FITC-PV-LA, was detected ( Figure 2B and C). These data indicate that a calcium ion-independent GlcNAc-binding lectin can be detected by FITC-PVGlcNAc ligand blot analysis in cardiomyocytes and VSMCs.
To determine the identity of these lectin-binding bands, the insoluble cellular fractions were resolved by 2D gel electro-845 Fig. 1 . Carbohydrate adhesion assay with rat neonatal cardiomyocytes, rat VSMCs and rat hepatocytes using 96-well plates coated with various PV-sugars. (A and C) Adhesion of cardiomyocytes (A) and VSMCs (C) to various PV-sugars. Cardiomyocytes and VSMCs (1 × 10 4 cells/well) were incubated at 4°C for 1 h in 96-well plates coated with a 100-μg/mL solution of various PV-sugars. (B and D) Dose-dependent inhibition of adhesion of cardiomyocytes (B) and VSMCs (D) to PV-GlcNAc-coated wells using soluble PV-GlcNAc and PV-MA. (E and F) Calcium dependency of the adhesion of cardiomyocytes (E) and VSMCs (F) to PV-GlcNAc-coated wells. (G) Adhesion of hepatocytes to 96-well plates coated with various PV-sugars. Hepatocytes (1 × 10 4 cells/well) were incubated at 4°C for 1 h in 96-well plates coated with a 100-μg/mL solution of various PV-sugars. Results are represented as average ± SD of more than three independent experiments. *P < 0.05 (versus other samples); #P < 0.05, ##P < 0.01 (PV-GlcNAc versus PV-MA). phoresis and then subjected to FITC-PV-GlcNAc ligand blot analysis and Coomassie brilliant blue (CBB) staining. These experiments revealed two major protein spots in the cardiomyocyte samples and one spot in the VSMC sample, which corresponded to an approximate molecular mass of 53 kDa and an isoelectric point of 5.1 ( Figure 2D -G). Protein sequence analysis revealed that the N-terminal sequence of the proteins in spots (i) and (ii) in Figure 2E were GTNESLERQMREME and MAEGVEIATYRELLE, respectively, and that in spot (iii) in Figure 2G was GTNESLENQMREMEE. A BLAST homology search and western blot analyses with anti-vimentin and antidesmin antibodies confirmed that protein spots (i) and (iii) are vimentin, and protein spot (ii) is desmin ( Figure 2H and I). Thus, vimentin and desmin were identified as GlcNAc-binding lectins.
Localization of vimentin and desmin to the cell surface If vimentin and desmin are GlcNAc-binding lectins on the cell surface, then these proteins should be localized on the cell surface. However, vimentin and desmin are generally considered to be localized in the cytoplasm. We therefore determined whether vimentin and desmin might also be expressed on the cell surface. For this purpose, the cell surface proteins of cardiomyocytes and VSMCs were specifically biotinylated, as described in the "Materials and methods." Biotinylated proteins in lysed cells were then purified in a pull-down assay using NeutrAvidin-immobilized agarose and analyzed by western blot analysis with antivimentin and anti-desmin antibodies. Both vimentin and desmin were detected in the pulled-down biotinylated cell fractions ( Figure 3A and C). In the converse experiment, both biotinylated vimentin and desmin were also detected by western blot analysis with horseradish peroxidase (HRP)-conjugated NeutrAvidin following immunoprecipitation with anti-desmin or anti-vimentin antibodies ( Figure 3B and D). The detection of N-cadherin (a surface protein of cardiomyocytes) and plateletderived growth factor β receptor (a surface protein of VSMCs), but not of intracellular β-actin, in the NeutrAvidin pull-down assay indicated that only cell surface proteins were biotinylated and that cytoplasmic proteins were not biotinylated ( Figure 3A and C) . The level of vimentin and desmin expressed on the cell surface was estimated by determination of the vimentin and desmin levels in the biotinylated fraction as a percentage of the respective vimentin and desmin levels in the total cell lysate. ( Figure 3E ). Vimentin accounted for 7.58 ± 3.66% and 13.53 ± 4.33% of the total biotinylated surface proteins in cardiomyocytes and VSMCs, respectively, and desmin accounted for 12.56 ± 1.26% of the total biotinylated surface proteins in cardiomyocytes.
To determine whether the distribution of vimentin and desmin on the cell surface coincided with the distribution of GlcNAcbinding lectins on the cell surface, we assayed the cell surface distribution of these molecules using confocal laser microscopy.
To ensure staining of vimentin, desmin, and a GlcNAc-binding lectin only on the cell surface, viable cells were directly incubated with anti-vimentin or anti-desmin antisera (raised using a whole protein immunogen) or with FITC-PV-GlcNAc in the absence of fixation. The cell surface staining pattern of the GlcNAc-binding lectin was similar to those of vimentin and desmin in cardiomyocytes ( Figure 4A-F) and VSMCs ( Figure 4G-I) . Intracellular actin was not stained in cardiomyocytes under the same experimental conditions, indicating that cell integrity was preserved and that the antibodies used did not penetrate the cytoplasm ( Figure 4J ). Furthermore, little nonspecific staining was observed with unrelated goat or rabbit antisera (normal serum). Therefore, anti-vimentin and antidesmin antisera appeared to recognize cellular fractions of vimentin and desmin proteins that are present on the cell surface.
These results suggest that a protein fraction of cellular vimentin and desmin is expressed on the extracellular membrane and that this fraction binds to PV-GlcNAc.
Analysis of the ability of vimentin and desmin to bind PV-GlcNAc using surface plasmon resonance To quantify GlcNAc binding of vimentin and desmin, the interaction between these purified proteins and PV-LA, poly
(PV-MA) or PV-GlcNAc was analyzed using the BIAcore®3000 or J system. PV-GlcNAc, but not PV-LA or PV-MA, strongly bound to vimentin and desmin ( Figure 5A and B, respectively). Using an affinity plot, the dissociation constants (K D s) for the binding of PV-GlcNAc to vimentin and desmin were determined as 2.18 × 10 −5 M and 5.35 × 10 −6 M, respectively. These results suggest that vimentin and desmin both bind strongly and specifically to GlcNAc.
Determination of the GlcNAc-binding site of vimentin and desmin using FITC-PV-GlcNAc ligand blotting and Biacore analyses Vimentin and desmin are type III intermediate filament proteins and are composed of head, rod Ia, rod Ib, rod II and tail domains ( Figure 5C ) (Paulin and Li 2004; Ivaska et al. 2007) . To determine the GlcNAc-binding site of vimentin and desmin, 6-His-tagged rod Ib and rod II domains of vimentin and desmin were synthesized as recombinant proteins, and the interaction of these purified proteins with GlcNAc was examined using FITC-PV-GlcNAc ligand blotting analysis ( Figure 5D ) and the Biacore system ( Figure 5E and F). The results revealed that the rod II domains of both vimentin and desmin, but not their rod Ib domains, bound to PV-GlcNAc ( Figure 5D-F) . These results suggest that the rod II domain is the GlcNAc-binding site in vimentin and desmin and that the domains other than the rod II do not bind to PV-GlcNAc. (D and E) and VSMCs (F and G) were resolved by 2D gel electrophoresis and subjected to ligand blot analysis with FITC-PV-GlcNAc (D and F) and CBB staining analysis (E and G). The major spots, (i), (ii) and (iii), were detected using ligand blot analysis. (H and I) The insoluble fractions of cardiomyocytes (H) and VSMCs (I) were resolved by 2D gel electrophoresis and were then subjected to ligand blot analysis with FITC-PV-GlcNAc, anti-vimentin antibodies and anti-desmin antibodies. The proteins in spots (i) and (iii) reacted with anti-vimentin antibodies; the protein in spot (ii) reacted with anti-desmin antibodies. Determination of the GlcNAc-binding site using point mutations in the vimentin-rod II domain Computational docking simulations of vimentin-rod II and PVGlcNAc binding indicated that E374, E375, E382, D385, D394 and E396 in the rod II domain are the amino acids involved in GlcNAc binding. To confirm this observation, 6-His-tagged recombinant vimentin-rod II domains with point mutations at these positions (E374A, E375A, E382A, D385A, D394A and E396A) were synthesized, and the interaction of these mutants with PV-GlcNAc was examined using the Biacore system. Biacore analysis indicated that mutant E396A could not interact with PV-GlcNAc and that the interaction of E382A was weak ( Figure 5G ). These results show that amino acids E382 and E396 in the rod II domain are important for the interaction between vimentin and PV-GlcNAc.
Determination of the sugar valency required for the interaction of PV-GlcNAc with vimentin
To determine the required sugar valency for the interaction between the vimentin-rod II domain and PV-GlcNAc, copolymers of GlcNAc containing varying amounts of PV-MA (to which vimentin does not bind) were prepared in the following P(VGlcNAc-co-VMA) ratios: 90:10, 85:15, 80:20 and 70:30. Since these copolymers were synthesized by the polymerization of VGlcNAc (GlcNAc monomer) and VMA (maltose monomer) in various ratios, VMA and VGlcNAc in the copolymer were arranged by equivalent uniform distribution. Therefore, if the structure is correct in nuclear magnetic resonance (NMR) analysis, the GlcNAc and MA are oriented periodically in ratios, and the valencies were determined by the mixture ratios of the monomers spontaneously. The structures of these copolymers were confirmed by NMR analysis. The PV-GlcNAc valency of these four P(VGlcNAc-co-VMA) copolymers was expected as 9, 5 or 6, 4 and 2 or 3, respectively. Analysis of the interaction of these copolymers with the vimentin-rod II domain using the Biacore J system indicated that P(VGlcNAc-co-VMA) at 90:10 and 85:15, but not at 70:30, interact with the vimentin-rod II domain to the same extent as PV-GlcNAc. The P(VGlcNAc-co-VMA) copolymer at 80:20 weakly interacted with vimentin-rod II ( Figure 5H ). These results suggest that the required valency of PV-GlcNAc for vimentin-rod II binding is greater than 4. Thus, PV-GlcNAc valencies of 5, 6 or 9 were determined to be sufficient for the interaction with vimentin.
3D structural docking simulation between PV-GlcNAc and the rod II domain
To examine the binding mechanism between PV-GlcNAc and vimentin, we performed 3D structural modeling of the binding between vimentin and PV-GlcNAc based on the computational docking simulations ( Figure 6 ). It has previously reported that the rod II domains functioned as tetrameric complexes and were confirmed to be a tetramer and higher molecular weight complexes (∼750 kDa, i.e. 16-mers) in solution, as measured by Naive-PAGE, dynamic light scattering and size exclusion chromatography (Soellner et al. 1985) . The rod II domain crystals contain three independent coiledcoil folds dimers per asymmetric unit, denoted AB, CD and EF, respectively (Strelkov et al. 2002) . Therefore, the 2-fold axis of the three rod II domain dimers may provide insights into the 2-fold axis of symmetry and the quaternary structural design of the entire rod II domain. The coordinates to the rod II domain of human vimentin were retrieved from the Protein Data Bank (accession code 1GK4), and the tetramer was generated using the XtalView (McRee 1999). Two dimers (C-, D-and their partners C′, D′) lie on the crystallographic 2-fold axis and have the same dimer interface, suggesting that interface consisted of the four C-terminal α-helices. For the molecular docking between PV-GlcNAc and vimentin-rod II domain, we constructed the compound and corrected its geometry. Then we added hydrogen atoms and assigned charges both to the rod II domain as protein and to PV-GlcNAc as substrate. We performed two sets of docking studies: one to dock substrate to the monomeric form of the rod II domain and the other to dock PV-GlcNAc to the active surface residues of the tetramer rod II domain. The molecular coordinates of the docked complex were energy minimized. Complexes with relatively the lower potential mean force score were chosen, and the negative values were termed as attractive "potential," i.e., −177.7 kcal/mol, −97.2 kcal/mol and −65.6 kcal/mol at E382 of C-chain, two E396 of Dchain and its crystallographic partner of D′-chain, respectively ( Figure 6 ).
Determination of the surface expression of the rod II domain
To determine whether the rod II domains of vimentin and desmin are expressed on the cell surface and are thus available for PV-GlcNAc binding, the expression of the rod II domain on the cell surface was immunocytochemically examined in viable, non-fixed, cardiomyocytes using a rabbit antiserum raised against the purified recombinant rod II domain of vimentin. Prior western blot analyses indicated that the anti-rod II domain antiserum specifically reacts with the rod II domains of both vimentin and desmin . This result is consistent with the fact that the amino acid sequence of the rod II domain of vimentin exhibits 77% identity to that of the rod II domain of desmin. Confocal laser microscopy showed that the cell surfaces of cardiomyocytes were similarly stained with the anti-rod II domain antiserum and with FITC-PV-GlcNAc but not with anti-vimentin (V9) or anti-desmin antibody, which recognizes the C-terminal domains of the respective protein, nor with preimmune serum that was used as a negative control (Figure 7E and G) . These results demonstrated that the rod II domain, but not the C-terminal domain, of vimentin and desmin localized to the cell surface where it directly binds to FITC-PVGlcNAc. Double immunostaining images of the rod II domain and N-cadherin on the cell surface further confirmed the surface localization of the rod II domain ( Figure 7F ). In permeabilized and fixed cardiomyocytes, the anti-rod II domain antiserum reacted with both intracellular vimentin and desmin, and the staining patterns were similar to that obtained with the anti-C-terminal anti-vimentin (V9) and anti-desmin antibodies, respectively ( Figure 7H ). In contrast to the intracellular staining pattern of vimentin and desmin, the extracellular staining patterns of these proteins had a punctuate appearance. This result suggests that only a fraction of the total cellular vimentin and desmin (the rod II domain) is exposed on the cell surface.
Interaction of vimentin and desmin with PV-GlcNAc in various cells
To further clarify the role of vimentin in cell adhesion to GlcNAc, the adhesion of various cells, which express vimentin and desmin at various levels, to GlcNAc-coated wells was examined. The adhesion of cardiomyocytes to PV-GlcNAc-coated wells was inhibited by approximately 40% when the cells were transfected with anti-desmin siRNA ( Figure 8A ), which reduced desmin levels by approximately 60% ( Figure 8B) . Furthermore, the cell adhesion assay indicated that H9c2, HeLa, COS-1 and A7r5 cells, as well as human umbilical vein endothelial cells (HUVECs) (all vimentin-expressing cells) adhered to PVGlcNAc-coated wells, whereas human bronchial epithelial cells and rat primary hepatocytes, which express low levels of vimentin, did not adhere to the wells ( Figure 8C and D) . Thus, these results indicate that vimentin plays a role in cell binding to PVGlcNAc. Some carcinoma cell lines such as HepG2 and MCF-7 reportedly do not express vimentin (Pieper et al. 1992; Srisomsap et al. 2004; McInroy and Määttä 2007) . Nevertheless, these carcinoma cells could adhere to PV-GlcNAc-coated wells ( Figure 8E ). However, reverse transcriptase polymerase chain reaction (RT-PCR) analysis using vimentin-specific probes ( Figure 8F ), as well as ligand blotting analysis using FITC-PV-GlcNAc ( Figure 8G ), indicated that some of these carcinomas express a vimentin variant and can recognize PV-GlcNAc.
Endocytosis of GlcNAc-Ls into cardiomyocytes by vimentin and desmin
We previously reported that cardiomyocytes could effectively take up 0.1-0.8 µm GlcNAc-Ls into the cell (Aso et al. 2007 ). To determine whether the internalization of GlcNAc-Ls depends on vimentin and desmin, the cellular localization of vimentin and desmin was investigated using electron microscopic preembedding immunocytochemistry after GlcNAc-Ls were incubated with cultured cardiomyocytes for 2 h at 37°C. When cardiomyocytes internalized GlcNAc-Ls ( Figure 9A and B, arrows), vimentin and desmin were detected on the parts of the cell surface that were in contact with GlcNAc-Ls ( Figure 9A and B, arrowheads and intense black areas). Since these specimens were stained without lead and uranium, the cell membranes, nuclei and organelles were not strongly stained ( Figure 9C ). Moreover, since immunostaining was performed following fixation, it is possible that the antibodies used might have penetrated the cytoplasm. Therefore, the intense black areas indicate immunostaining of vimentin and desmin both on the cell surface and in the cytoplasm. To determine whether GlcNAc-Ls induce the localization of vimentin and desmin to the cell surface and/or their internalization, the recruitment of vimentin and desmin to the cell surface and their phosphorylation, which may play a role in their membrane recruitment, were further examined following the addition of GlcNAc-Ls to cardiomyocytes. Analysis of vimentin and desmin on the cell surface using the biotin pull-down assay described for Figure 3 showed a higher level of biotinylated vimentin and desmin following incubation with GlcNAc-Ls than after incubation with MA-Ls or after a control incubation without liposomes ( Figure 9D ). The phosphorylation of vimentin and desmin, which was assayed using an anti-phosphoserine pull-down assay, was also higher following incubation with GlcNAc-Ls than with MA-Ls or following a control incubation in the absence of liposomes ( Figure 9E ). Both the recruitment of vimentin and desmin to the cell surface and their phosphorylation were inhibited by 100 nM GF109203X, a protein kinase C (PKC) inhibitor ( Figure 9F and G). Since vimentin has been reported to be secreted by activated macrophages in a PKC-dependent manner (Mor-Vaknin et al. 2003) , the membrane recruitment of vimentin and desmin to cell surfaces may thus be regulated by PKC. As PKC plays a critical role in the internalization of GlcNAcLs, these results suggest that vimentin and desmin are recruited to the cell surface in order to internalize GlcNAc-Ls. Thus, vimentin and desmin may be involved in the internalization of GlcNAc-bearing molecules.
Interaction of His-tagged vimentin-rod II domain protein with O-GlcNAc proteins
What are physiological ligands for vimentin and desmin? In Figure 5 , it was revealed that the putative physiological ligands have a valency higher than 4. We assumed that vimentin might interact with multimerized O-GlcNAc proteins, as multimerization of O-GlcNAc proteins has been widely reported. To determine whether vimentin interacts with O-GlcNAc proteins, we performed immunocytochemistry and pull-down assay with His-tagged vimentin-rod II domain protein for HeLa cells. Immunocytochemistry with the recombinant His-tagged vimentin-rod II domain and anti-O-GlcNAc antibodies was performed in the fixed and permeabilized HeLa cells. The Histagged vimentin-rod II proteins were added to the HeLa cells, and the interacted His-tagged proteins were detected with antiHis-tag antibodies. Confocal laser microscopy indicated that various O-GlcNAc proteins were stained by anti-O-GlcNAc antibodies, and the His-tagged vimentin-rod II protein also interacted with various proteins in HeLa cells intracellularly ( Figure 10A and B) . In both immunostaining analyses, HeLa cells were similarly stained with the His-tagged vimentin-rod II domain and anti-O-GlcNAc antibodies intracellularly ( Figure 10C ). Both stainings were inhibited by the addition of PV-GlcNAc, and recombinant vimentin-Ib protein did not also interact with HeLa cells (Figure 10D-G) . His-tagged vimentinrod II domain pull-down assay and western blotting with anti-OGlcNAc antibodies were performed in HeLa cell lysate. The western blot analysis indicated that some O-GlcNAc proteins were precipitated by the pull-down assay ( Figure 10H ). Moreover, the precipitation with the pull-down assay was inhibited by coexistence with 1 mg/mL PV-GlcNAc but not 1 mg/mL PV-MA. In the pull-down assay with His-tagged desmin-rod II domain protein, the same O-GlcNAc proteins were also detected similarly to that with His-tagged vimentin-rod II domain protein (Supplemental Figure 1A) . These results demonstrated that vimentin-rod II domain could specifically bind to some OGlcNAc proteins. The precipitation of these O-GlcNAc proteins could be detected in HeLa cell lysate prepared by lysis buffer containing 3-((3-cholamidopropyl)dimethylammonio)-1-propanesulfonic acid (CHAPS) but not containing Nonidet P-40 (NP-40) because the lysis buffer containing CHAPS was considered to lyse proteins of HeLa cells under milder conditions than that containing NP-40 (data not shown). CHAPS but not NP-40 is suspected to solubilize many proteins of HeLa cells in keeping with complex formation of proteins. Therefore, the precipitated O-GlcNAc proteins appeared to form complexes and be multimerized. Moreover, the interactions of mucin from bovine submaxillary glands and gangliosides (asialo-GM1 and asialo-agalacto-GM1) with vimentin-rod II domain were examined as other candidates for the physiological ligands by Biacore because these have sialic acids or N-acetylgalactosamine (GalNAc). In the examination of gangliosides, liposomes containing the asialo-GM1 and the asialo-agalacto-GM1 (the non-reducing terminus is GalNAc residue) were prepared. In Biacore analysis, mucin and these liposomes could not interact with vimentin-rod II domain specifically (Supplemental Figure 1B These findings suggested that the physiological ligands of vimentin and desmin might be multimerized O-GlcNAc proteins.
Discussion
Despite the fact that vimentin and desmin are very important for cell function, it has been reported that the phenotypes of vimentin-or desmin-deficient mice are rather mild and that these mice develop normally and are fertile (Colucci-Guyon et al. 1994; Li et al. 1997 ). This leaves the exact physiological roles of vimentin and desmin elusive (Ivaska et al. 2007 ). This study showed a novel role for vimentin and desmin as lectin-binding proteins on the cell surface of cardiomyocytes and VSMCs. The finding that vimentin is expressed on the cell surface is consistent with previous studies which have reported that vimentin exists on the cell surface and is secreted into the extracellular space by natural killer cells (Garg et al. 2006) , activated macrophages (Mor-Vaknin et al. 2003 ) and endothelial cells (Xu et al. 2004) . The functions of surface-expressed and secreted vimentin have been reported to be related to the promotion of innate immunity. Since Biacore analysis showed that vimentin-rod II domain could not interact with lipopolysaccharide (data not shown), the GlcNAc-binding properties of vimentin and desmin on cell surfaces may not be involved in cellular innate immunity.
Type III intermediate filament proteins such as vimentin and desmin are composed of head, rod and tail domains, among which the distal head and tail domains possess many phosphorylated sites, and the rod domains form an α-helical structure (Paulin and Li 2004; Ivaska et al. 2007 ). Interestingly, the present confocal laser microscopy and surface plasmon resonance studies revealed that the rod II domain on cell surfaces has a high affinity for PV-GlcNAc. The amino acid sequence of the rod II domain of vimentin exhibits approximately 70-80% identity to that of the rod II domains of other type III intermediate filament proteins such as glial fibrillary acidic protein (GFAP) (70%), peripherin (76%) and desmin (77%). Based on their high sequence identity, the rod II domains of peripherin and GFAP should also interact with GlcNAc on cell surfaces. Therefore, the interaction of the rod II domain with GlcNAc on cell surfaces may be a common function of these type III intermediate filament proteins. Although transmembrane domains of vimentin and desmin remain unclear, it has been reported that some domains of vimentin have high affinity for lipid bilayer. The presence of vimentin in the endoplasmic reticulum may be explained by the presence of a highly positively charged aminoterminal domain that can react with the hydrophobic core of the lipid bilayer and direct it into membranes (Perides et al. 1987 ). In addition, D394-L403 (-DIEIATYRKL-) in the vimentin-rod II domain is a di-acidic motif (Asp-X-Glu, where X is any amino acid) preceded by a Tyr-X-X-ϕ motif (where ϕ is bulky hydrophobic residue), which is known to be required for selective export of certain proteins from the endoplasmic reticulum into the Golgi and is found in many membrane-associated proteins (Nishimura and Balch 1997) . Supplemental Figure 1C showed that all the liposomes slightly interacted with vimentin-rod II domain. This result demonstrates that vimentin-rod II domain may have high affinity for lipid bilayer and include transmembrane domains.
The rod II domains are reported to be self-assembled and to form a coiled-coil structure (Lu et al. 1995; Strelkov et al. 2002) , one of which has been previously reported to span the cell membrane (Strelkov et al. 2001 ). The coiled-coil structure of the rod II domain may thus be important for the recognition of GlcNAc on cell surfaces. This is the first report that a coil-coil structure is involved in sugar binding. The 3D structural modeling revealed that the rod II domains form tetramers following interaction with PV-GlcNAc and allowed prediction of the docking sites of PVGlcNAc in the tetrameric form of the rod II domains. The binding of PV-GlcNAc to the rod II domain stabilized the 2-fold dimer conformation of the rod II domain. This result suggests that the 2-fold symmetric conformation represents an active form of the rod II domain, confirming that the PV-GlcNAc-binding mechanism of the rod II domain involves transitions between dimeric and tetrameric forms. A stable tetrameric form of the rod II domain protein is required for lectin binding.
PV-GlcNAc but not a series of monosaccharide residues could bind to the rod II domain. Thus, the binding of only one molecule of GlcNAc to the rod II domain would not be sufficient to stabilize the 2-fold conformation. Although the physiological relevance of the binding of vimentin and desmin to PV-GlcNAc is currently unclear, the theoretical prediction for the mode of docking PV-GlcNAc to the rod II domains should be relevant for the lectin binding of vimentin and desmin.
Mutation residue D385A in the rod II domain rather activates than does not inhibit the formation of a complex between PVGlcNAc and the rod II domain. Since D385 lies on the dimer interface with the rod II domain and directly contacts it through hydrogen bonding, the mutation presumably disrupts the tertiary structure of the rod II domain helical bundle. This residue suggests that its mutation would disrupt higher polymerization of the rod II domain. Mutation of these E382 and E396 but not that of D385 and D394 in the rod II domain inhibits the binding of PV-GlcNAc. Therefore, activation of PV-GlcNAc binding by these mutants would appear to result from the destabilization of the tetramer-of-dimers (8mer) arrangement of the rod II domain. During the docking calculations, flexible PV-GlcNAc docking of the flexible side chain of the rod II domain was performed. It was predicted to form hydrogen bonds with four or six functional groups of E382 and E396 in the docked -(-CH2-CH-benzen ring-GlcNAc)4-. We found that PVGlcNAc binding induces a state in the rod II domain capable of polymerizing but at a great affinity for tetramer formation. These results explain the assembly of the rod II domain tetramers by PV-GlcNAc in cells. The immunocytochemistry and pull-down assay with vimentin-rod II domain demonstrated that vimentin-rod II domain interacted with some O-GlcNAc proteins in HeLa cells. It has been reported that vimentin intracellularly interacts with nuclear membrane proteins and wheat germ agglutinin (GlcNAc-binding lectin)-binding proteins (GlcNAc-bearing proteins) (Maison et al. 1993) . Therefore, we suggest that OGlcNAc proteins may be a candidate for the physiological ligands of vimentin and desmin. This study also showed that GlcNAc-Ls are internalized through vimentin and desmin and that GlcNAc-Ls augment the membrane recruitment and phosphorylation of these proteins. Cellular localization of vimentin and desmin may fluctuate in a dynamic manner based on the presence or absence of their lectin ligands. It is likely that extracellular physiological ligands that bind to, and are actively internalized by, vimentin and desmin have a valency higher than 4. From these findings, we propose that extracellular physiological ligands of vimentin and desmin are also multimerized OGlcNAc proteins. Apoptotic and necrotic cells are predicted to release many O-GlcNAc proteins as cellular debris. Vimentin and desmin are expected to bind to and internalize these OGlcNAc proteins that are extracellularly released from other dying cells on the cell surface. We speculate that the GlcNAc-binding lectin-like properties of vimentin and desmin on the cell surface are involved in the clearance of O-GlcNAc proteins as cellular debris caused by cell injury or death.
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In conclusion, this study showed that the rod II domain of vimentin and desmin is present on the cell surface and has lectin-like activity toward GlcNAc. These findings are expected to contribute to the elucidation of novel mechanisms of embryogenesis, tumor metastasis, and epithelial-mesenchymal transitions, all of which involve GlcNAc glycosylation. Moreover, understanding such mechanisms should prove useful for the development of drug and cell delivery systems for the treatment of various diseases (Aso et al. 2007; Kobayashi et al. 2009 ).
Materials and methods
Cell culture
The cardiomyocytes, VSMCs, hepatocytes, normal human bronchial epithelial cells and H9c2, HeLa, COS-1, A7r5, HepG2, MCF-7, HuH-7 and Hepa1-6 cells (6.25 × 10 4 cells/ cm 2 ) were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (FBS) at 37°C in 95% air/5% CO 2 . HUVECs were cultured in EBM-2 medium (Cambrex Bio Science Walkersville, Inc., Walkersville, MD, USA) at 37°C in 95% air/5% CO 2 . The cells were detached using Accutase (Innovative Cell Technologies, Inc., La Jolla, CA, USA) and a cell detachment solution (Invitrogen Corp., Carlsbad, CA, USA), and the detached cells were washed and suspended in phosphate-buffered saline (PBS). Cardiomyocytes were isolated from the ventricles of 1-day-old Sprague-Dawley rats by digestion with trypsin and collagenase, as described previously (Ikeda et al. 2001) . Rat primary hepatocytes were isolated from the livers of Sprague-Dawley rats by in situ collagenase perfusion, as described previously (Ise et al. 2004 ). VSMCs were isolated from the abdominal aorta of adult Sprague-Dawley rats by digestion with trypsin and collagenase, as described previously (Takahashi et al. 2002) . Normal human bronchial epithelial cells were gifted by Dr. Yasuo. Bronchial samples were obtained from 20 patients (mean age, 64 ± 3.1 years) who had undergone lung resection because of lung cancer or benign lung tumors. The Ethics Committee of the Shinshu University School of Medicine approved the study, and the patients provided written informed consent to participate in the study. Human bronchial epithelial cells were isolated as described by Yasuo et al. (2006) . HUVECs were obtained from Dainippon-Sumitomo Pharma (Osaka, Japan).
Carbohydrate adhesion assay
Aliquots (100 μL) of 100 μg/mL PV-sugar aqueous solutions were added to 96-well suspension culture plates and incubated overnight at 37°C, as described previously (Ise et al. 2001 ). The PV-sugars were purchased from Seikagaku Corp. (Tokyo, Japan) and Celagix Research Ltd. (Yokohama, Japan). The surfaces of the polymer-coated wells were then blocked by incubation with a 0.02 mg/mL solution of BSA in Hank's balanced salt solution (HBSS) for 1 h at 4°C. The cells, suspended in HBSS, were seeded onto the polymer-coated wells at a density of 1 or 2 × 10 4 cells/well and incubated for 1 h at 4°C. After incubation, the unbound cells were removed by washing with PBS. The number of adhered cells was estimated using the MTT assay (Aso et al. 2007 ).
Ligand blot analysis using FITC-PV-GlcNAc Cells were lysed in a lysis buffer (10 mM Tris-HCl, 150 mM NaCl, 1% NP-40, 10 mM EDTA, 2 mM phenylmethylsulfonyl fluoride (PMSF) and a protease inhibitor cocktail [Nacalai Tesque, Kyoto, Japan]; pH 7.4). The cell lysate was separated to obtain the soluble (supernatant) and insoluble (pellet) fractions by centrifugation (20,000 × g) for 30 min at 4°C. These fractions were resolved by 10% SDS-PAGE under reducing conditions. In order to renature the proteins in the gel for binding assays, SDS was removed by soaking the gel in 2.5% Triton X-100 for 1 h at room temperature, following which the proteins were renatured by zymographic techniques (Lantz and Ciborowski 1994 ). The renatured proteins were then transferred to polyvinylidene difluoride. The membranes were incubated with 0.4 µg/mL FITC-PV-GlcNAc (Celagix), then with rabbit polyclonal anti-FITC IgG antibodies (Biogenesis Ltd., Brentwood, NH, USA) (1:20,000) and finally with HRP-conjugated anti-rabbit IgG antibodies (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA) (1:20,000). The membranes were developed using Immobilon Western detection reagents (Millipore Corp., Billerica, MA, USA) according to the manufacturer's instructions.
Identification of (a) GlcNAc-binding lectin(s) from cardiomyocytes and VSMCs using 2D gel electrophoresis The insoluble fractions were lysed in a urea buffer (5 mM TrisHCl, 8 M urea, and 2% CHAPS) . These lysates were mixed with a loading buffer (7 M urea, 2 M thiourea, 4% CHAPS, 2.8 mg/mL 1,4 dithiothreitol and 0.5% linear immobilized pH gradient (IPG) buffer [pH range: 3-10, 4.5-5.5 or 4-7] ). Isoelectrophoresis in an IPG gel of pH 3-10, 4.5-5.5 or 4-7 and length 13 or 18 cm was carried out using commercially available strips by following the manufacturer's instructions (Ettan IPGphor III; GE Healthcare UK Ltd., Amersham Place, UK), while 2D gel electrophoresis was performed using 10% SDS-PAGE (SE 600 Ruby; GE Healthcare UK Ltd.). After 2D gel electrophoresis, protein spots on the gel were subjected to FITC-PV-GlcNAc ligand blot analysis and visualized using the SeePico CBB stain kit (Seoul, South Korea). The CBBstained spots recognized by FITC-PV-GlcNAc were excised, and the proteins in the spots were analyzed by peptide mapping and protein sequence analysis (Shimadzu PPSQ-21A; Shimadzu Corp., Kyoto, Japan) as described previously (Omori et al. 2002) . A BLAST homology search was performed using the obtained N-terminal sequence in order to identify the proteins.
Biotinylation of cell surface proteins using sulfosuccinimidyl N-(D-biotinyl)-6-aminohexanoate (biotin-AC 5 -Sulfo-Osu) To biotinylate all cell surface proteins of cardiomyocytes and VSMCs, the cultured cells were incubated with 100 μg/mL Biotin-AC5-Sulfo-Osu (Dojindo, Kumamoto, Japan) at 4°C for 30 min (Marmorstein et al. 1998; Kioi et al. 2003) . Biotin-AC 5 -Sulfo-Osu cannot enter the cytoplasm since it is a water-soluble reagent; therefore, only cell surface proteins are biotinylated. After incubation, these cells were incubated with HBSS containing 0.1% BSA for 5 min to quench the unreacted reagent and were then washed thrice with HBSS.
Biacore® analysis of the interaction between PV-sugars and vimentin or desmin Binding analysis was performed using the Biacore 3000 or J system and BIAevaluation 3.0.2 software (BIAcore, Uppsala, Sweden) as described previously (Montalto et al. 2001) . Purified vimentin from a bovine lens and desmin from a chicken gizzard were purchased from PROGEN Biotechnik GmbH (Heidelberg, Germany). Vimentin, desmin and the purified rod Ib and II domains of both vimentin and desmin were immobilized on a CM5 sensor chip using an amine coupling kit (BIAcore), according to the manufacturer's instructions. Briefly, these proteins were immobilized by injecting a 100-µg/mL solution of the proteins (pH 4.0) in 10 mM acetate buffer (pH 4.5).
Immobilization was completed by injecting 1 M ethanolamine hydrochloride to block the remaining ester groups. The association of PV-LA, PV-MA or PV-GlcNAc with these proteins was determined. These polymers were diluted in a running buffer (10 mM HEPES, 150 mM NaCl, 2.7 mM KCl, 3 mM EDTA and 0.005% Tween 20; pH 7.4) and injected at a rate of 20 μL/min for 3 min. Each polymer was separated by 2 min of dissociation time and 1 min of regeneration with 10 mM glycine-HCl solution (pH 3). Each sensorgram represents the relative response after subtraction of the reference flow cell (unimmobilized flow cell). The dissociation constants (K D s) of PV-GlcNAc for vimentin and desmin were determined from an affinity plot of various concentrations of PV-GlcNAc (10-200 μg/mL; GlcNAc ligand monomer in 10 μg/mL PV-GlcNAc = 18 μM) using the BIAevaluation 3.0.2 software. Various P(VGlcNAc-co-VMA) were synthesized by Celazix Res. Ltd.
Pull-down assay and western blot analysis
After incubation, the cultured cells were washed thrice with HBSS. The cardiomyocyte samples in which inhibition of PKC was required were treated with 100 nM GF109203X (Calbiochem, Darmstadt, Germany) for 2 h. The cells were lysed in a lysis buffer (25 mM Tris-HCl, 2.5 mM EDTA, 137 mM NaCl, 2.7 mM KCl, 1% sodium deoxycholic acid, 0.1% SDS, 1% Triton X-100, 2 mM PMSF, 50 mM NaF, 25 mM glycerophosphate, 1 mM sodium orthovanadate and a protease inhibitor cocktail [Nacalai Tesque]). In His-tagged vimentinrod II pull-down assay, to keep with the conformation of many proteins, HeLa cells were lysed in a lysis buffer (500 mM aminocapronic acid, 1% CHAPS, 50 mM Bis/Tris [pH 7.0], 2 mM PMSF and a protease inhibitor cocktail). The lysate was centrifuged at 20,000 × g for 30 min at 4°C. The supernatants containing equal amounts of proteins were incubated with protein A/G-conjugated agarose beads (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) bound to mouse monoclonal antivimentin antibodies (V9) (Sigma, St. Louis, MO, USA) or rabbit polyclonal anti-desmin antibodies (LAB vision Corp., Fremont, CA, USA) (20 μL), protein L-conjugated agarose beads (Santa Cruz) bound to anti-phosphoserine antibodies (Biomol, PA, USA) (20 μL), NeutrAvidin-conjugated beads (Pierce, Rockford, IL, USA) (20 μL) or His-tagged vimentinrod II domain beads that were prepared by nickel nitrilotriacetic acid-conjugated beads (Millipore) (50 μL) at 4°C overnight (Kioi et al. 2003; Marmorstein et al. 1998) . After incubation, the proteins bound to these beads were resolved by 10% SDS-PAGE. Western blot analysis was performed by incubation with either HRP-conjugated NeutrAvidin (Pierce) (1:5000), mouse monoclonal anti-vimentin antibodies (1:10,000), rabbit polyclonal anti-desmin antibodies (1:10,000), rabbit anti-rod II domain antiserum (1:5000), rabbit polyclonal anti-N-cadherin antibodies (Santa Cruz) (1:200), rabbit polyclonal anti-platelet-derived growth factor β receptor (PDGFβR) antibodies (Santa Cruz) (1:200), mouse monoclonal anti-β-actin antibodies (Sigma) (1:10,000) or anti-OGlcNAc antibodies (Covance, Emeryville, CA,USA); this was followed by incubation with appropriate HRP-conjugated secondary antibodies. The membranes were developed using Immobilon Western detection reagents (Millipore). The densitometric analysis was performed by a computer-assisted desitometry (Image J, version 1.38X, National Institutes of Health, MD, USA).
Construction of plasmids and purification of N-terminal 6-His-tagged rod Ib and rod II domains of vimentin and desmin The cDNA fragments encoding the rod Ib and II domains of vimentin and desmin were amplified from the cDNA of rat cardiomyocytes by polymerase chain reaction ( PrimeSTAR HS DNA Polymerase (Takara Bio Inc., Shiga, Japan). PCR amplification of the rod Ib domain of vimentin and desmin, which are encoded by amino acids (aa) 149-231 and aa 153-235 respectively, was performed using the following primers containing the XhoI or BamHI digestion sites: vimentin sense primer, 5′-CCGCTCGAGCGGCTC-TACGAGGAGGAGATGAG-3′, and antisense primer, 5′-CGGGATCCCGAATTTCTTCCTGCAAGGATT-3′; desmin sense primer, 5′-CCGCTCGAGCGGCTCTAC-GAGGAGGAGATGCG-3′, and antisense primer, 5′-CGGGATCCCGAATCTCCTCGTTGAGTGACTC-3′. PCR amplification of the rod II domain of vimentin and desmin, which are encoded by aa 288-406 and aa 292-410, respectively, was performed using the following primers containing the XhoI or BamHI digestion sites: vimentin sense primer, 5′-CCGCTCGAGCGGGAGGAATGGTA-C A A G T C C A A C -3 ′ , a n d a n t i s e n s e p r i m e r , 5 ′ -CGGGATCCCGCCCTTCCAGCAGCTTCCTGTC-3′; desmin sense primer, 5′ -CCGCTCGAGCGGGAA-GAATGGTACAAGTCCAAG-3′, and antisense primer, 5′-CGGGATCCCGGCCCTCCAGCAGCTTCCGGTA-3′. These cDNA fragments were subcloned into the pMD20-T vector of a Mighty TA-cloning Kit for PrimeSTAR (Takara Bio Inc., Shiga, Japan). The resulting plasmids were digested with XhoI and BamHI. Recombinant plasmids expressing 6-His-tagged rod Ib or rod II domains of vimentin and desmin were constructed by ligating the XhoI/BamHI-digested cDNA fragments with the XhoI/BamHI-digested pET14b vector. Recombinant proteins were expressed in Escherichia coli BL21(DE3) cells and purified using a Novagen His-Bind Purification Kit (EMD Chemicals, Inc., San Diego, CA, USA) according to the manufacturer's instructions. Each construct of point mutant was prepared using a TaKaRa PrimeSTAR Mutagenesis Basal Kit according to the manufacturer's instructions.
Production of rabbit antiserum against the rod II domain of vimentin The production of rabbit antiserum against the rod II domain of vimentin was entrusted to OPERON Biotechnologies, K.K. (Tokyo, Japan). Briefly, two rabbits were immunized by the rod II domain of vimentin fusion protein as an immunogen. After 7 weeks of immunization, rabbit serum was collected. Preimmune serum was used as a negative control.
Confocal laser scanning microscopy Cells were cultured on 24 × 24 mm glass cover slips. For staining only the cell surfaces, all cultures were incubated with goat anti-vimentin antiserum (Sigma) (1:20), rabbit anti-desmin antiserum (Sigma) (1:20), rabbit anti-rod II domain antiserum (1:50), monoclonal anti-β-actin antibodies (Sigma) (1:1000), monoclonal anti-vimentin antibodies (V9) (1:40), goat polyclonal anti-desmin antibodies (C-terminal domain) (Santa Cruz) (1:100), mouse monoclonal anti-N-cadherin antibodies (Abcam plc, Cambridge, UK) (1:25) or 100 μg/mL FITC-PV-GlcNAc in HBSS containing 10% FBS at 4°C for 1 h under viable conditions without fixation and permeabilization, as described previously (Hembrough et al. 1995) . Goat antivimentin and rabbit anti-desmin antiserum were developed using purified whole vimentin and desmin as the immunogen, respectively. These cells were then incubated with Cy3-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories, Inc.) (1:100) for 1 h at 4°C, rinsed thrice, and fixed in 4% paraformaldehyde (PFA)/PBS for 15 min. In the negative control experiments, rabbit or goat normal serum (1:20) or rabbit preimmune serum (1:50) was substituted for primary antiserum. For staining of intracellular proteins, all cultures were fixed in 4% PFA/PBS for 15 min, washed with 50 mM glycine-PBS, permeabilized with 0.1% Triton X-100/PBS for 5 min and blocked with a 10% FBS solution in HBSS for 1 h. After fixation and permeabilization, cells were incubated for 1 h with rabbit anti-rod II domain antiserum (1:50), monoclonal anti-vimentin antibodies (V9) (1:40) and goat polyclonal anti-desmin antibodies (C-terminal domain) (Santa Cruz) (1:100). In the staining of O-GlcNAc proteins in HeLa cell, after fixation and permeabilization, the cells were incubated for 1 h with anti-O-GlcNAc antibodies (Pierce) (1:200) and 20 μg/mL His-tagged vimentinrod II or vimentin-rod Ib domain proteins and then were incubated for 1 h with anti-His tag antibodies (Santa Cruz) (1:100). The inhibition experiment of PV-GlcNAc was performed by the addition of 200 μg/mL PV-GlcNAc for 1 h. These cells were then washed thrice with HBSS and incubated with Cy3-or FITC-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories, Inc.) (1:100) for 1 h at room temperature. The nucleus was stained with 0.1 μg/mL diamino-2-phenylindole (DAPI) (Sigma). Confocal laser scanning microscopy was carried out using the Leica TCS SP2 System (Leica Microsystems Vertrieb GmbH, Wetzlar, Germany) with a 63×/1.40-0.60 lens (HCX PL APO; Oil λ BL; Leica) at room temperature. To obtain z stacks, we acquired 10-20 optical sections over approximately 0.5-1 μm. Fluorescent images were processed with the Leica LCS Lite software (Leica).
RT-PCR
Total RNA was isolated from cells using Isogen Reagent (Nippon Gene Co., Ltd., Tokyo, Japan) according to the manufacturer' s instructions. The first-strand cDNAs were synthesized using Omniscript reverse transcriptase (Qiagen). For 861 
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RT-PCR, the following primers were used: human vimentin sense primer, GGCAGAAGAATGGTACAAATCC, and antisense primer, CTTCCAGCAGCTTCCTGTAG; mouse vimentin sense primer, CTGTACGAGGAGGAGATGCG, and antisense primer, AATTTCTTCCTGCAAGGATT; human glyceraldehydes 3-phosphate dehydrogenase sense primer, AGTCAACGGATTTGGTCGTA, and antisense primer, AAATGAGCCCCAGCCTTCT; and mouse β-actin sense primer, CCTGAGCGCAAGTACTCTGTGT, and antisense primer, GCTGATCCACATCTGCTGGAA. PCR was performed using TopTaq DNA polymerase (Qiagen).
siRNA knockdown experiments
The siRNAs for rat desmin and negative controls (AllStars Negative Controls) were obtained from Qiagen GmbH (Hilden, Germany). The siRNA for rat desmin targeted the sequence CTGGCTATTGGCAACTGTCAA (nucleotides 1679-1699 of rat desmin mRNA, NM_022531). Cardiomyocytes were plated onto 6-cm dishes at a density of 6.25 × 10 4 cells/cm 2 and were transfected with 5 nM desmin siRNA using HiPerFect Transfection Reagent (Qiagen) according to the manufacturer's instructions. The AllStars Negative Control siRNA (Qiagen) was used as the negative control. Three days after transfection, cardiomyocytes were analyzed using a carbohydrate adhesion assay and western blot analysis.
3D structural docking simulation between PV-GlcNAc and the rod II domain All calculations were performed using the BioMedCAChe Workspace program (v6.1.1, Fujitsu Ltd, Tokyo, Japan) the MOPAC 2002 program, which was implemented in the MO-ZYME algorithm (Stewart, J.J.P., Fujitsu Ltd, Tokyo, Japan). This program constructs a 3D grid, which is 20 Å cubic docking boxes surrounding the center of the docking site. The substrate positions and binding site conformations obtained from automated docking were analyzed by means of default values. Docking runs were carried out with 0.3 Å spacing and computed for each atom type and electrostatic potential using the lamarckian genetic algorithm as implemented in FastDock. Standard parameters were used: a population size of 50 individuals, a mutation rate of 0.2, a crossover rate of 0.8 and local search probabilities of 0.06 with a maximum of 300 iterations. To exhaustively search each binding surface residues of the rod II domain tetramer, orientations were rapidly scored using an energy grid with a 6-9 attractive-repulsive van der Waals potential and the electrostatic term weighted by 0.01. The energy minimization option was active with default values. A bump filter was employed to discard orientations with 80 out of 83 major steric clashes. Residues E382, D394 and E396 were mutated to alanine prior docking, as their side chains. Additional docking studies were conducted using their rod II domain mutants E382A and E396A as well as PVGlcNAc. The best orientation was obtained from this procedure by probability mass function (PMF) predictions, significantly lower in energy than the other orientations. At the completion of each trial, the PMF score can be calculated as quickly as the potential interaction energy, using a standard energy function (Sippl et al. 1996; Muegge and Martin 1999) .
Liposome preparation Liposomes were prepared as described previously (Aso et al. 2007 ). The liposomes were composed of dipalmitoyl phosphatidylcholine:dipalmitoyl phosphatidylethanolamine:cholesterol (80:2:20, molar ratio) (NOF Corp., Tokyo, Japan). Liposomes (total lipids, 102 μmol) were prepared using an extruder (Avanti Polar Lipids, Inc., AL, USA). GlcNAc-and MA-conjugated liposomes (MA-Ls) were prepared by the incorporation of PVGlcNAc and PV-MA, respectively, into the liposome surface.
To incorporate these PV-sugars into the liposome surface easily, the polymers were covalently linked to alkyl chains. We have confirmed that these polymers adsorbed on the liposome surface (Aso et al. 2007 ).
Transmission electron microscopy combined with pre-embedding immunocytochemistry Cardiomyocytes were cultured on glass cover slips according to the procedure used for the confocal laser scanning microscopy experiments. The cells were incubated with GlcNAc-Ls for 2 h at 37°C. After incubation, the cells were washed thrice with HBSS, fixed with 4% PFA/PBS for 15 min, rinsed thrice again and incubated with rabbit anti-vimentin antiserum and goat antidesmin antiserum as primary antibodies at 4°C overnight; this was followed by incubation with appropriate HRP-conjugated secondary antibodies. For electron microscopic pre-embedding immunocytochemistry, diaminobenzidine (DAB) was used as a substrate for HRP (Kuriyama et al. 2004 ). In the negative control experiments, primary antibodies were excluded. To fix the plasma membranes and the liposomes and to form osmium black (DAB-osmium complex), we incubated the cells with 1% osmium tetroxide in 0.1 M phosphate buffer for 1 h at 4°C. The cells were then serially dehydrated in ethanol and embedded in EPON 812 for polymerization at 60°C for 1 day. The embedded cells were thin sectioned, and these sections, which were 100 nm thick, were placed on copper grids. The sections were examined with a JEOL 1200EX transmission electron microscope at room temperature.
Statistical analyses
All data are expressed as the mean ± standard deviation (SD) of more than three independent experiments, and statistical analyses of two groups were performed using the unpaired Student's t test. A probability (P) value of <0.05 was considered to be significant.
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